Suchergebnisse - "IL-6 antagonist"

PubPharm (11)

1

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients : results from a real-world cohort

enthalten in: Infection | 2023

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

2

A Prospective Cohort Study of COVID-19 : Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Al Kharusi, M. | Al Sheikh, N. | Alhajri, M. | +5

3

A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death

in: Healthcare | 2023

von Mardheya Al. Kharusi | Naffesa Al Sheikh | Maiya Alhajri | +5

4

Interleukin-6 Antagonists : Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection

enthalten in: Journal of pharmacy practice | 2022

von Meanwatthana, J. | Majam, T.

5

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort

enthalten in: Infection | 2022

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

6

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort

enthalten in: Infection | 2022

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

7

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort

enthalten in: Infection | 2022

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

8

IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

enthalten in: Cytokine | 2022

von Kow, C. | Zaihan, A. | Ramachandram, D. | +1

9

Reduction of venous thromboembolic events in COVID-19 patients : Which role for IL-6 antagonists?

enthalten in: Thrombosis research | 2021

von Zuin, M. | Cervellati, C. | Rigatelli, G. | +2

CommentOn: J Thromb Haemost. 2020 May;18(5):1023-1026. - PMID 32338827

10

Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)

enthalten in: Expert opinion on pharmacotherapy | 2021

von Gutierrez, M. | Mur, I. | Mateo, M. | +2